Inceptor Bio logo

Inceptor Bio

Advancing Cell and Gene Therapies to Cure Cancer

28 employees · est. 2020 · Morrisville, United States

VS
Matterhorn Biosciences logo

Matterhorn Biosciences

M-TCR cell therapies targeting a new hallmark of cancer

7 employees · est. 2020 · Basel, Switzerland

Inceptor Bio is the larger of the two.

Side-by-Side Comparison

Inceptor Bio Matterhorn Biosciences
Founded
2020 2020
Headquarters
Morrisville, United States Basel, Switzerland
Employees
28 larger 7
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Debt Financing Series Unknown
Total Funding
$87.65M $30.00M
Funding Rounds
5 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cell Therapy, Gene Therapy, Cancer Treatment, Immunotherapy, Tumor Microenvironment, Oncology, Cancer Research, Immune Cell Performance, Novel Mechanisms, Next-generation Therapies Cell Therapy, Cancer Treatment, MR1-directed Therapy, T Cell Receptors, Cancer-Specific Metabolites, Immunotherapy, M-TCR Platform, Oncology, Cancer Immunology, Cellular Therapies, Biopharmaceuticals
Website
inceptor.bio matterhornbiosciences.com
Inceptor Bio logo

About Inceptor Bio

Inceptor Bio is a biotechnology startup, founded in 2020, headquartered in the United States. The company's slogan, "Advancing Cell and Gene Therapies to Cure Cancer," reflects its mission to develop next-generation cell therapy platforms aimed at curing difficult-to-treat cancers. Inceptor Bio's fo...

Matterhorn Biosciences logo

About Matterhorn Biosciences

Matterhorn Biosciences, established in 2020, is pioneering a breakthrough in the biopharmaceutical sector with its focus on MR1 directed cell therapy. Positioned as a leader, the company leverages its proprietary M-TCR cell therapy platform to target the underlying mechanisms of cancer. Operating o...

We will tell you when either one moves

BounceWatch watches Inceptor Bio and Matterhorn Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Inceptor Bio and Matterhorn Biosciences — by email.

Frequently Asked Questions

Inceptor Bio — Advancing Cell and Gene Therapies to Cure Cancer. Matterhorn Biosciences — M-TCR cell therapies targeting a new hallmark of cancer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Inceptor Bio has raised $87.65M while Matterhorn Biosciences has raised $30.00M.
Inceptor Bio and Matterhorn Biosciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Inceptor Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Inceptor Bio on 11 Sep 2024, and Matterhorn Biosciences on 29 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy